References
- Arnold M, Singh D, Laversanne M et al. (2022) Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol 158:495–503.
https://doi.org/10.1001/jamadermatol.2022.0160 - Belote RL, Le D, Maynard A et al. (2021) Human melanocyte development and melanoma dedifferentiation at single-cell resolution. Nat Cell Biol 23:1035–1047.
https://doi.org/10.1038/s41556-021-00740-8 - Callegari I, Oechtering J, Schneider M et al. (2024) Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5. Brain 147:839–848.
https://doi.org/10.1093/brain/awad424 - Chen C, Wang L, Cui XF et al. (2025) SCARA5 deficiency inhibits ferroptosis via regulating iron homeostasis and results in sorafenib resistance in hepatocellular carcinoma. Cell Signal 129:111656.
https://doi.org/10.1016/j.cellsig.2025.111656 - Cullison CR, Tripathi R, Bordeaux JS (2022) Identifying sociodemographic factors associated with hospitalization following primary excision of cutaneous melanoma. J Am Acad Dermatol 86:681–683.
https://doi.org/10.1016/j.jaad.2021.02.070 - Desaunay M, Poulikakos PI (2025) Overcoming melanoma therapy resistance with RAF-MEK and FAK inhibition. Cancer Cell 43:330–332.
https://doi.org/10.1016/j.ccell.2025.02.012 - Gao W, Wang X, Zhou Y et al. (2022) Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther 7:196.
https://doi.org/10.1038/s41392-022-01046-3 - Lei G, Zhuang L, Gan B (2024) The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell 42:513–534.
https://doi.org/10.1016/j.ccell.2024.03.011 - Liu J, Hu G, Chen D et al. (2013) Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis 2:e73.
https://doi.org/10.1038/oncsis.2013.37 - Liu N, Zhang J, Yin M et al. (2021) Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization. Mol Ther 29: 2321–2334.
https://doi.org/10.1016/j.ymthe.2021.03.013 - Liu Y, Nishiura M, Fujii M et al. (2024) Selective Pyk2 inhibition enhances bone restoration through SCARA5-mediated bone marrow remodeling in ovariectomized mice. Cell Commun Signal 22:561.
https://doi.org/10.1186/s12964-024-01945-8 - Luan Y, Yang Y, Luan Y et al. (2024) Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases. J Zhejiang Univ Sci B 25:1–22.
https://doi.org/10.1631/jzus.B2300097 - Polesie S, Gillstedt M (2022) Psoriasis and risk of cutaneous melanoma: a retrospective, comparative, registry-based cohort study. J Am Acad Dermatol 86:215–217.
https://doi.org/10.1016/j.jaad.2021.01.084 - Ren K, Pei J, Guo Y et al. (2023) Regulated necrosis pathways: a potential target for ischemic stroke. Burns Trauma 11:tkad016.
https://doi.org/10.1093/burnst/tkad016 - Scatolini M, Patel A, Grosso E et al. (2022) GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma. Br J Dermatol 186:117–128.
https://doi.org/10.1111/bjd.20629 - Shi Y, Yang X, Jiang H et al. (2024) Curcumin exerts anti-inflammatory, antioxidant and anti-ferroptotic effects through the Nrf2/HO-1 pathway to protect cardiomyocytes against sepsis. Signa Vitae 20:46–53.
https://doi.org/10.22514/sv.2024.057 - Suhr A, Choi JJ, Levine TC (2022) Cutaneous melanoma with metastasis to the lateral rectus muscle. Ophthalmology 129:1021.
https://doi.org/10.1016/j.ophtha.2022.03.002 - Swystun LL, Michels A, Lillicrap D (2023) The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis. J Thromb Haemost 21:2007–2019.
https://doi.org/10.1016/j.jtha.2023.04.014 - Yang R, Gao W, Wang Z et al. (2024) Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis. Phytomedicine 122:155135.
https://doi.org/10.1016/j.phymed.2023.155135 - Yellapu NK, Ly T, Sardiu ME et al. (2022) Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer. BMC Cancer 22:627.
https://doi.org/10.1186/s12885-022-09690-2